| Krebs Biochemicals & Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524518 |
NSE Symbol : KREBSBIO |
P/E(TTM) : - |
|
ISIN Demat : INE268B01013 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : -60.36 |
Market Cap(₹Cr) : 219.92 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.86 | 12.89 | 11.97 | 12.98 | 14.89 | 10.58 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.86 | 12.89 | 11.97 | 12.98 | 14.89 | 10.58 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.09 | 0.03 | 0.21 | 0.03 | 0.17 | 0.04 |
| Total Income | 12.94 | 12.92 | 12.18 | 13.01 | 15.06 | 10.62 |
| Total Expenditure | 15.57 | 15.09 | 15.09 | 15.07 | 15.79 | 13.20 |
| PBIDT | -2.62 | -2.16 | -2.90 | -2.06 | -0.73 | -2.58 |
| Interest | 1.42 | 1.32 | 1.27 | 1.19 | 1.13 | 1.10 |
| PBDT | -4.05 | -3.48 | -4.18 | -3.25 | -1.86 | -3.68 |
| Depreciation | 1.71 | 1.69 | 1.67 | 1.73 | 1.71 | 1.65 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -5.76 | -5.17 | -5.85 | -4.98 | -3.57 | -5.33 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -5.76 | -5.17 | -5.85 | -4.98 | -3.57 | -5.33 |
| EPS (Unit Curr.) | -2.67 | -2.40 | -2.72 | -2.31 | -1.66 | -2.47 |
| EPS (Adj) (Unit Curr.) | -2.67 | -2.40 | -2.72 | -2.31 | -1.66 | -2.47 |
| Calculated EPS (Unit Curr.) | -2.67 | -2.40 | -2.71 | -2.31 | -1.66 | -2.47 |
| Calculated EPS (Adj) (Unit Curr.) | -2.67 | -2.40 | -2.71 | -2.31 | -1.66 | -2.47 |
| Calculated EPS (Ann.) (Unit Curr.) | -10.69 | -9.59 | -10.85 | -9.23 | -6.63 | -9.89 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -10.69 | -9.59 | -10.85 | -9.23 | -6.63 | -9.89 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -20.37 | -16.76 | -24.23 | -15.87 | -4.90 | -24.39 |
| PBDTM(%) | -31.49 | -27.00 | -34.92 | -25.04 | -12.49 | -34.78 |
| PATM(%) | -44.79 | -40.11 | -48.87 | -38.37 | -23.98 | -50.38 |